GET DAILY SIGNALSMarsh & McLennan (MMC) Posts Solid Q3 2026 Beat with Revenue and +10% EPS Growth
Key Takeaways
- Marsh & McLennan reported third-quarter 2026 revenue of $6.86 billion, beating the consensus estimate of $6.64 billion.
- Adjusted earnings per share (EPS) came in at $2.03, above analyst expectations of $1.97 and up 10% from $1.85 a year earlier.
- Underlying revenue grew 5%, with strong contributions from Management Consulting, which rose 14%, and the Risk division, up 5%.
- The Reinsurance business declined 6% amid a soft pricing environment and a tough year-ago comparison.
- Management raised its Thrive cost-savings target from $400 million to $600 million to fund further reinvestment in sales and technology.
- Shares moved higher following the release, reflecting investor approval of the revenue and earnings beat.
Earnings Context and Why It Matters
Marsh & McLennan Companies (MMC) is a global professional services firm operating across risk, insurance, and consulting through businesses including Marsh, Guy Carpenter, Mercer, and Oliver Wyman. Its quarterly results serve as a closely watched barometer for the commercial insurance brokerage and advisory industry. The third quarter arrived against a backdrop of softening global insurance rates, which pressure brokerage commissions, making the company's ability to grow underlying revenue especially significant. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Investors also tracked progress on the Thrive efficiency program and the company's recently completed brand transition, both of which are central to management's margin-expansion story. This earnings report matters because it shows whether diversified consulting growth can offset weaker conditions in reinsurance and property pricing.
Reported Results
For the third quarter ended September 30, 2026, Marsh & McLennan reported consolidated revenue of $6.86 billion, up 8% year over year and ahead of the $6.64 billion consensus estimate. Underlying revenue grew 5%. Adjusted EPS was $2.03, exceeding the $1.97 consensus and rising 10% from $1.85 in the prior-year period, while GAAP EPS was $1.69. Adjusted operating income rose 6% to $1.5 billion, with an adjusted operating margin of 22.7%.
Segment performance was mixed. Risk and Insurance Services (RIS) revenue grew 7% to $4.2 billion, with the Risk division up 10% on a reported basis and 5% on an underlying basis. Consulting revenue increased 9% to $2.7 billion, led by Management Consulting's 14% growth to $1.0 billion. People and Investments revenue rose 6% to $1.7 billion. In contrast, Reinsurance revenue fell 6% to $374 million as soft market conditions weighed on results. Assets under management (AUM) reached $843 billion, up 23% year over year.
Market Reaction and Investor Sentiment
The market responded positively to the results, with Marsh & McLennan shares moving higher following the October 15, 2026 release. The revenue and adjusted EPS beats reinforced the view that the firm can sustain growth even as property insurance rates decline, with global rates down about 5% in the quarter. Investors appeared to focus on the strength in Management Consulting and the Risk division, as well as the upsized Thrive savings target, which signals additional room for margin expansion and reinvestment. At the same time, the decline in Reinsurance and continued soft pricing in property lines remain areas of caution for analysts evaluating the durability of top-line momentum heading into year-end.
Forward Outlook and Key Factors to Monitor
Management reiterated expectations for underlying revenue growth in 2026 similar to the prior year, alongside another year of margin expansion and solid adjusted EPS growth. The raised Thrive savings target of $600 million, with associated costs of roughly $750 million, is a key lever to watch, as management plans to redirect savings into sales capacity, new products, and technology.
Artificial intelligence (AI) is emerging as a central theme. The company is deploying AI-enabled tools such as Marsh Risk Companion and has highlighted AI consulting demand as a driver of Management Consulting growth. Investors should monitor how quickly these investments translate into measurable productivity gains and client-facing revenue.
On the risk side, several factors bear watching. Reinsurance pricing remains soft, and management expects fiduciary interest income to decline further in the fourth quarter. Litigation costs tied to Greensill totaled $144 million in the quarter, adding to noteworthy items. Finally, global insurance rate trends and the January 1 reinsurance renewal cycle will help determine whether revenue momentum in the Risk and Reinsurance businesses can stabilize. These dynamics, rather than any single-quarter figure, will likely shape investor sentiment over the coming quarters.
Exploring Tickeron’s AI Tools for Deeper Analysis
In my own research process, I often turn to Tickeron’s AI Screener when evaluating earnings movers like MMC. It allows me to quickly filter stocks by industry, technical patterns, and fundamentals, helping surface comparable ideas without spending hours on manual screens. The tool’s AI-driven signals have proven useful for spotting trends in the insurance and consulting sectors, giving me additional context beyond the headline numbers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
MRSH in upward trend: price rose above 50-day moving average on October 15, 2026
MRSH moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on MRSH as a result. In 46 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 48%.
Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 162 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
The Aroon Indicator entered an Uptrend today. In 99 of 264 cases where MRSH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.
Bearish Trend Analysis
The 10-day RSI Indicator for MRSH moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 15 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 64 cases where MRSH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
MRSH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.438) is normal, around the industry mean (2.681). P/E Ratio (24.948) is within average values for comparable stocks, (19.012). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.019) settles around the average of (0.039) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (2.968).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InsuranceBrokersServices
Advertisement